Peptide Nucleic Acid Clamping and Direct Sequencing in the Detection of Oncogenic Alterations in Lung Cancer: Systematic Review and Meta-Analysis

키워드

참고문헌 (28)

1. Reck M, "Precision diagnosis and treatment for advanced non-small-cell lung cancer", N Engl J Med, 377, pp.849~861 (2017)[DOI]
2. Won JK, "Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor", Ann Oncol, 26, pp.348~354 (2015)[DOI]
3. Lindeman NI, "Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology", Arch Pathol Lab Med, 137, pp.828~860 (2013)[DOI]
4. Pao W, "Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method", Clin Cancer Res, 13, pp.4954~4955 (2007)[DOI]
5. Kim HS, "Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR tyrosine kinase inhibitors in non-small-cell lung carcinoma", PLoS One, 8, pp.e81975~ (2013)[DOI]
6. 이계영, "비소세포폐암에서 PNA-Mediated PCR Clamping을 이용한 EGFR 돌연변이 분석법", Tuberculosis and Respiratory Diseases, 69(4), pp.271~278 (2010), 대한결핵및호흡기학회
7. Yeo CD, "Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing", Lung Cancer, 81, pp.207~212 (2013)[DOI]
8. Sakurada A, "Tissue heterogeneity of EGFR mutation in lung adenocarcinoma", J Thorac Oncol, 3, pp.527~529 (2008)[DOI]
9. Taniguchi K, "Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib", Cancer Sci, 99, pp.929~935 (2008)[DOI]
10. Yeh YC, "Pulmonary adenocarcinoma with microcystic histology and intratumoral heterogeneity of EGFR gene polymorphism", Histopathology, 57, pp.112~120 (2010)[DOI]
11. Yatabe Y, "Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma", J Clin Oncol, 29, pp.2972~2977 (2011)[DOI]
12. Moher D, "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement", Ann Intern Med, 151, pp.264~269 (2009)[DOI]
13. Whiting P, "The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews", BMC Med Res Methodol, 3, pp.25~ (2003)[DOI]
14. Reitsma JB, "Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews", J Clin Epidemiol, 58, pp.982~990 (2005)[DOI]
15. Thompson SG, "Why sources of heterogeneity in meta-analysis should be investigated", BMJ, 309, pp.1351~1355 (1994)[DOI]
16. Lijmer JG, "Empirical evidence of design-related bias in studies of diagnostic tests", JAMA, 282, pp.1061~1066 (1999)[DOI]
17. Deeks JJ, "The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed", J Clin Epidemiol, 58, pp.882~893 (2005)[DOI]
18. Han HS, "Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity", J Thorac Oncol, 7, pp.355~364 (2012)[DOI]
19. Kang JY, "Comparison of PNA clamping and direct sequencing for detecting KRAS mutations in matched tumour tissue, cell block, pleural effusion and serum from patients with malignant pleural effusion", Respirology, 20, pp.138~146 (2015)[DOI]
20. 김희정, "EGFR 돌연변이 검출에 있어 PNA-Mediated Real-Time PCR Clamping과 직접 염기서열 분석법의 비교 분석", Tuberculosis and Respiratory Diseases, 70(1), pp.21~27 (2011), 대한결핵및호흡기학회
21. Kim HJ, "Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with nonsmall cell lung cancer", Lung Cancer, 75, pp.321~325 (2012)[DOI]
22. 이현주, "Comparison of Direct Sequencing, PNA Clamping-Real Time Polymerase Chain Reaction, and Pyrosequencing Methods for the Detection of EGFR Mutations in Non-small Cell Lung Carcinoma and the Correlation with Clinical Responses to EGFR Tyrosine Kinase Inhibitor Treatment", Journal of Pathology and Translational Medicine, 47(1), pp.52~60 (2013), 대한병리학회
23. 이보람, "KRAS Mutation Detection in Non-small Cell Lung Cancer Using a Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping Method and Comparative Validation with Next-Generation Sequencing", Journal of Pathology and Translational Medicine, 48(2), pp.100~107 (2014), 대한병리학회[DOI]
24. Min KW, "Comparison of EGFR mutation detection between the tissue and cytology using direct sequencing, pyrosequencing and peptide nucleic acid clamping in lung adenocarcinoma: Korean multicentre study", QJM, 109, pp.167~173 (2016)[DOI]
25. 윤성훈, "Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer", Cancer Research and Treatment, 47(4), pp.661~669 (2015), 대한암학회[DOI]
26. Endo K, "Epidermal growth factor receptor gene mutation in nonsmall cell lung cancer using highly sensitive and fast TaqMan PCR assay", Lung Cancer, 50, pp.375~384 (2005)[DOI]
27. Pirker R, "Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop", J Thorac Oncol, 5, pp.1706~1713 (2010)[DOI]
28. Dinnes J, "A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy", Health Technol Assess, 9(12) (2005)

관련 논문AI추천